With 1.85 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.28 million shares. The 52-week range on CRI shows that it touched its highest point at $88.03 and its lowest point at $39.88 during that stretch. It currently has a 1-year price target of $45.75. With its current market cap of 1.49 billion, CRI has annualized dividend of $3.20 while the current yield stands at 7.71%. Beta for the stock currently stands at 1.05.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRI was up-trending over the past week, with a rise of 1.59%, but this was down by -17.66% over a month. Three-month performance dropped to -25.71% while six-month performance fell -38.80%. The stock lost -50.05% in the past year, while it has lost -23.42% so far this year. A look at the trailing 12-month EPS for CRI yields 5.13 with Next year EPS estimates of 3.84. For the next quarter, that number is 0.54. This implies an EPS growth rate of -34.22% for this year and 0.40% for next year. EPS is expected to decline by -14.34% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -2.63%.
Float and Shares Shorts:
At present, 36.04 million CRI shares are outstanding with a float of 34.80 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRI since 2 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $5.37789 being high and $5.2741 being low. For CRI, this leads to a yearly average estimate of $5.32212. Based on analyst estimates, the high estimate for the next quarter is $0.45 and the low estimate is $0.2. The average estimate for the next quarter is thus $0.33.
